focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Repurchase of Fortel shares

26 Apr 2011 07:00

RNS Number : 4237F
China Private Equity Inv Hldgs Ld
26 April 2011
 



China Private Equity Investments Holdings Limited

("CPE" or the "Company")

 

The Company's principal activity is to invest in growth companies operating in Greater China

 

 

 

Repurchase of Fortel ordinary shares

 

The Board of CPE is pleased to announce that Fortel BVI ("Fortel"), one of its portfolio companies, has repurchased 5,503 of the ordinary shares of US$ 0.01 in Fortel held by CPE TMT Holdings Limited ("CPE TMT"), a wholly owned subsidiary of CPE.

The repurchase is at an agreed price of US$690.50 per share and values Fortel at US$72 million. CPE retains a residual 33.60% stake in Fortel, from 37.1% previously. The repurchased shares will be cancelled.

The agreement by Fortel to repurchase the shares from CPE TMT follows the issue by Fortel of a US$6.8 million convertible loan note to Amazing Quality Investments Limited, which is a wholly owned subsidiary of Asia Private Credit Fund Limited, a fund managed by Gen2 Partners Investment Management Limited (www.gen2partners.com). The convertible loan note, which has a coupon of 12%, will convert into Fortel shares representing approximately 9% of the issued share capital at the time of a public listing of Fortel shares.

Of the US$6.8 million raised by the issue of the convertible loan note, US$3.8 million has been paid to CPE for the repurchase of the Fortel shares, and US$3 million will be used by Fortel as general working capital for business expansion ahead of its planned listing on the Hong Kong Stock Exchange later this year.

CPE plans to use the US$3.8 million raised by the transaction to provide further funding for its core objectives of investing in companies that operate in China, have significant exposure to the Chinese market, or aim to benefit from CPE's experience in order to enter the Chinese market.

Hong Kong-based Fortel is well positioned to become the premier electronic content publishing and distribution network in Greater China by providing an integrated content distribution platform known as the Fortel Online Content Utility System ("FOCUS") to support convergent, streaming, and social media services. FOCUS enables content providers to deliver their content to customers by integrating content servers, payment collection and settlement interfaces, customer databases as well as network security services.

Fortel also operates a social networking site in China called iHompy (www.ihompy.com), which is a leading community site with over half a million registered users connected through a common theme of photography and photo storage. It works closely with leading search engines and e-commerce operators in China such as Baidu (www.baidu.com) and Taobao (www.taobao.com).

In 2009, Fortel achieved profits of HK$34 million (US$4.6 million).

The repurchase of CPE's shares in Fortel is deemed to be a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies as prior to the transaction, Duncan Chui, Chief Executive of CPE, was beneficially interested in 45.0% of Fortel shares. Following the cancellation of Fortel shares, his beneficial holding has increased to 47.8%. The directors of the Company, excluding Duncan Chui, having consulted with Shore Capital and Corporate Limited, the Company's nominated advisor, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

CPE Chief Executive Duncan Chui said: "This realisation of value in Fortel marks an important step forward for CPE at the end of our first 18 months on AIM, in line with our commitment to provide solid returns for shareholders. Fortel is now in the run up to a listing of its own, and as with our acquisition last month of a stake in Enfinium, we continue to seek further opportunities to capitalise on the growth potential waiting to be unlocked in China."

 

For further information, please visit www.cpe-invest.com or contact:

 

China Private Equity +852 2801 6770

Investments Holdings Limited

Duncan Chui / Ernest Wong

 

Shore Capital and Corporate +44 (0)20 7408 4090

Limited (Nominated Adviser)

Stephane Auton

 

First City / Tavistock +852 2854 2666

Public Relations

 Allan Piper

Simon Hudson / Lydia Eades

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGXGDSIGDBGBL
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.